Search research articles
Contact Us
Filters
Showing results (411-420 of 491) with videos related to
Page
of 50
Sort By:
Nature Immunology
|
March 26, 2021
Multi-omics analyses reveal that HIV-1 alters CD4<sup>+</sup> T cell immunometabolism to fuel virus replication
Haitao Guo, Qi Wang, Khader Ghneim, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
July 10, 2025
Energy status alters intestinal function and the gut microbiota during consecutive days of high energy demands
Cassandra Suther, Adrienne Hatch-McChesney, Jillian T Allen, et al.
Cell Reports
|
February 2, 2017
Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation
Alberto Bosque, Kyle A Nilson, Amanda B Macedo, et al.
Contemporary Clinical Trials Communications
|
July 19, 2021
Effects of testosterone undecanoate on performance during multi-stressor military operations: A trial protocol for the Optimizing Performance for Soldiers II study
Alyssa N Varanoske, Melissa N Harris, Callie Hebert, et al.
Journal of Neurovirology
|
March 10, 2015
HIV eradication symposium: will the brain be left behind?
B J Brew, K Robertson, E J Wright, et al.
The American Journal of Clinical Nutrition
|
November 13, 2020
Energy deficit increases hepcidin and exacerbates declines in dietary iron absorption following strenuous physical activity: a randomized-controlled cross-over trial
Stephen R Hennigar, James P McClung, Adrienne Hatch-McChesney, et al.
AIDS (London, England)
|
April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection
Cynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.
Open Forum Infectious Diseases
|
May 20, 2025
Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1
Cynthia L Gay, Jessica Keys, JoAnn D Kuruc, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2012
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
Nancie M Archin, Naveen K Vaidya, Joann D Kuruc, et al.
The Journal of Infectious Diseases
|
February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
Timothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
Page
of 50
Search research articles
Search
Showing results (411-420 of 491) with videos related to
Sort By:
Page
of 50
Nature Immunology
|
March 26, 2021
Multi-omics analyses reveal that HIV-1 alters CD4<sup>+</sup> T cell immunometabolism to fuel virus replication
Haitao Guo, Qi Wang, Khader Ghneim, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
July 10, 2025
Energy status alters intestinal function and the gut microbiota during consecutive days of high energy demands
Cassandra Suther, Adrienne Hatch-McChesney, Jillian T Allen, et al.
Cell Reports
|
February 2, 2017
Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation
Alberto Bosque, Kyle A Nilson, Amanda B Macedo, et al.
Contemporary Clinical Trials Communications
|
July 19, 2021
Effects of testosterone undecanoate on performance during multi-stressor military operations: A trial protocol for the Optimizing Performance for Soldiers II study
Alyssa N Varanoske, Melissa N Harris, Callie Hebert, et al.
Journal of Neurovirology
|
March 10, 2015
HIV eradication symposium: will the brain be left behind?
B J Brew, K Robertson, E J Wright, et al.
The American Journal of Clinical Nutrition
|
November 13, 2020
Energy deficit increases hepcidin and exacerbates declines in dietary iron absorption following strenuous physical activity: a randomized-controlled cross-over trial
Stephen R Hennigar, James P McClung, Adrienne Hatch-McChesney, et al.
AIDS (London, England)
|
April 14, 2011
Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection
Cynthia L Gay, Ashley J Mayo, Chelu K Mfalila, et al.
Open Forum Infectious Diseases
|
May 20, 2025
Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1
Cynthia L Gay, Jessica Keys, JoAnn D Kuruc, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2012
Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
Nancie M Archin, Naveen K Vaidya, Joann D Kuruc, et al.
The Journal of Infectious Diseases
|
February 5, 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes
Timothy J Wilkin, John E McKinnon, A Gregory DiRienzo, et al.
Page
of 50